Research & Literature

Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes.

Cinti F, Bouchi R, Kim-Muller JY, et al.

The Journal of clinical endocrinology and metabolism 2016; (101(3)):1044-54 doi:10.1210/jc.2015-2860.

Partners' representations of diabetes as mediators between patients' representations and adherence to self-care behaviors, in type 2 diabetes.

Pereira MG, Pedras S, Machado JC, Ferreira G

Psychology, health & medicine 2016; (21(6)):707-14 doi:10.1080/13548506.2015.1118517.

Diabetes Mellitus and Heart Failure.

Lehrke M, Marx N

The American journal of cardiology 2017; (120(1S)):S37-S47 doi:10.1016/j.amjcard.2017.05.014.

Autophagy and its link to type II diabetes mellitus.

Yang JS, Lu CC, Kuo SC, et al.

BioMedicine 2017; (7(2)):8 doi:10.1051/bmdcn/2017070201.

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology.

Shahim B, De Bacquer D, De Backer G, et al.

Diabetes care 2017; (40(9)):1233-1240 doi:10.2337/dc17-0245.

Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease.

Pedersen BK

European journal of clinical investigation 2017; (47(8)):600-611 doi:10.1111/eci.12781.

Regulation of hepatic glucose metabolism in health and disease.

Petersen MC, Vatner DF, Shulman GI

Nature reviews. Endocrinology 2017; (13(10)):572-587 doi:10.1038/nrendo.2017.80.

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.

Wanner C, Lachin JM, Inzucchi SE, et al.

Circulation 2018; (137(2)):119-129 doi:10.1161/CIRCULATIONAHA.117.028268.

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial.

Lean ME, Leslie WS, Barnes AC, et al.

Lancet (London, England) 2018; (391(10120)):541-551 doi:10.1016/S0140-6736(17)33102-1.

The Effect of Diabetes Self-Management Education on Hba1c Level and Fasting Blood Sugar in Type 2 Diabetes Mellitus Patients in Primary Health Care in Binjai City of North Sumatera, Indonesia.

Rusdiana , Savira M, Amelia R

Open access Macedonian journal of medical sciences 2018; (6(4)):715-718 doi:10.3889/oamjms.2018.169.

Screening for diabetes with HbA1c: Test performance of HbA1c compared to fasting plasma glucose among Chinese, Malay and Indian community residents in Singapore.

Lim WY, Ma S, Heng D, et al.

Scientific reports 2018; (8(1)):12419 doi:10.1038/s41598-018-29998-z.

Fifty years of pancreatic islet pathology in human type 1 diabetes: insights gained and progress made.

Morgan NG, Richardson SJ

Diabetologia 2018; (61(12)):2499-2506 doi:10.1007/s00125-018-4731-y.

Cardiovascular outcomes in diabetic kidney disease: insights from recent clinical trials.

Rocha NA, McCullough PA

Kidney international supplements 2018; (8(1)):8-17 doi:10.1016/j.kisu.2017.10.004.

Effect of Roux-en-Y gastric bypass surgery on diabetes remission and complications in individuals with type 2 diabetes: a Danish population-based matched cohort study.

Madsen LR, Baggesen LM, Richelsen B, Thomsen RW

Diabetologia 2019; (62(4)):611-620 doi:10.1007/s00125-019-4816-2.

Utility of Real-Time and Retrospective Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.

Ida S, Kaneko R, Murata K

Journal of diabetes research 2019; (2019()):4684815 doi:10.1155/2019/4684815.

Document on a comprehensive approach to type 2 diabetes mellitus.

Reyes-García R, Moreno-Pérez Ó, Tejera-Pérez C, et al.

Endocrinologia, diabetes y nutricion 2019; (66(7)):443-458 doi:10.1016/j.endinu.2018.10.010.

Pharmacological Management of Diabetic Nephropathy.

Papademetriou V, Alataki S, Stavropoulos K, et al.

Current vascular pharmacology 2020; (18(2)):139-147 doi:10.2174/1570161117666190405164749.

Understanding the mechanisms of reversal of type 2 diabetes.

Taylor R, Al-Mrabeh A, Sattar N

The lancet. Diabetes & endocrinology 2019; (7(9)):726-736 doi:10.1016/S2213-8587(19)30076-2.

Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta-Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials.

Giugliano D, Maiorino MI, Bellastella G, et al.

Journal of the American Heart Association 2019; (8(12)):e012356 doi:10.1161/JAHA.119.012356.

Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update.

Dunlay SM, Givertz MM, Aguilar D, et al.

Circulation 2019; (140(7)):e294-e324 doi:10.1161/CIR.0000000000000691.

Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.

Zaharia OP, Strassburger K, Strom A, et al.

The lancet. Diabetes & endocrinology 2019; (7(9)):684-694 doi:10.1016/S2213-8587(19)30187-1.

Continuous Glucose Monitoring Versus Self-monitoring of Blood Glucose in Type 2 Diabetes Mellitus: A Systematic Review with Meta-analysis.

Janapala RN, Jayaraj JS, Fathima N, et al.

Cureus 2019; (11(9)):e5634 doi:10.7759/cureus.5634.

The pivotal relation between glucagon-like peptides, NFκB and inflammatory bowel disease.

Azmy Nabeh O, Ishak Attallah M, El-Sayed El-Gawhary N

Clinical and experimental pharmacology & physiology 2020; (47(10)):1641-1648 doi:10.1111/1440-1681.13361.

Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study.

Tanabe H, Saito H, Kudo A, et al.

Journal of clinical medicine 2020; (9(7)) doi:10.3390/jcm9072083.

Sodium-glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus.

Scheen AJ

Nature reviews. Endocrinology 2020; (16(10)):556-577 doi:10.1038/s41574-020-0392-2.

Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline.

Doyle-Delgado K, Chamberlain JJ, Shubrook JH, et al.

Annals of internal medicine 2020; (173(10)):813-821 doi:10.7326/M20-2470.

Pathophysiology of Type 2 Diabetes Mellitus.

Galicia-Garcia U, Benito-Vicente A, Jebari S, et al.

International journal of molecular sciences 2020; (21(17)) doi:10.3390/ijms21176275.

Diabetes Remission Status During Seven-year Follow-up of the Longitudinal Assessment of Bariatric Surgery Study.

Purnell JQ, Dewey EN, Laferrère B, et al.

The Journal of clinical endocrinology and metabolism 2021; (106(3)):774-788 doi:10.1210/clinem/dgaa849.

Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050.

Awad SF, Huangfu P, Dargham SR, et al.

Scientific reports 2020; (10(1)):21001 doi:10.1038/s41598-020-77970-7.

The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials.

Min T, Bain SC

Diabetes therapy : research, treatment and education of diabetes and related disorders 2021; (12(1)):143-157 doi:10.1007/s13300-020-00981-0.

Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment?

Veelen A, Erazo-Tapia E, Oscarsson J, Schrauwen P

Molecular metabolism 2021; (46()):101158 doi:10.1016/j.molmet.2020.101158.

2019 Health Care & Education Presidential Address: It's All About Access!

Youssef GA

Diabetes care 2021; (44(1)):1-7 doi:10.2337/dci20-0050.

Glycemic relapse in a collaborative primary care-based type 2 diabetes management program.

Wheeler SE, Struebing T, Drury RLC, et al.

Journal of the American Pharmacists Association : JAPhA 2021; (61(4)):476-483.e3 doi:10.1016/j.japh.2021.02.007.

Knowledge and practice of diabetic foot care - A scoping review.

Manickum P, Mashamba-Thompson T, Naidoo R, et al.

Diabetes & metabolic syndrome 2021; (15(3)):783-793 doi:10.1016/j.dsx.2021.03.030.

Effectiveness of diabetes self-management education (DSME) in type 2 diabetes mellitus (T2DM) patients: Systematic literature review.

Ernawati U, Wihastuti TA, Utami YW

Journal of public health research 2021; (10(2)) doi:10.4081/jphr.2021.2240.

From the Association of Diabetes Care & Education Specialists: The Role of the Diabetes Care and Education Specialist as a Champion of Technology Integration.

Scalzo P

The science of diabetes self-management and care 2021; (47(2)):120-123 doi:10.1177/0145721721995478.

Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study.

Slieker RC, Donnelly LA, Fitipaldi H, et al.

Diabetologia 2021; (64(9)):1982-1989 doi:10.1007/s00125-021-05490-8.

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus.

Yong J, Johnson JD, Arvan P, et al.

Nature reviews. Endocrinology 2021; (17(8)):455-467 doi:10.1038/s41574-021-00510-4.

Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

Frías JP, Davies MJ, Rosenstock J, et al.

The New England journal of medicine 2021; (385(6)):503-515 doi:10.1056/NEJMoa2107519.

Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care.

Jacob S, Krentz AJ, Deanfield J, Rydén L

Drugs 2021; (81(12)):1373-1379 doi:10.1007/s40265-021-01554-6.

Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial.

Cherney DZI, Cosentino F, Dagogo-Jack S, et al.

Clinical journal of the American Society of Nephrology : CJASN 2021; (16(9)):1345-1354 doi:10.2215/CJN.01130121.

The Correlation Between Blood Group Type and Diabetes Mellitus Type II: A Case-Control Observational Study From Pakistan.

Sharjeel S, Wasi M, Jafri A, et al.

Cureus 2021; (13(11)):e19898 doi:10.7759/cureus.19898.

Relationship between glycosylated hemoglobin and iron deficiency anemia: A common but overlooked problem.

Aydın B, Özçelik S, Kilit TP, et al.

Primary care diabetes 2022; (16(2)):312-317 doi:10.1016/j.pcd.2022.01.002.

Macrovascular Complications.

McRae M, Low Wang CC

Primary care 2022; (49(2)):255-273 doi:10.1016/j.pop.2021.11.012.

Newly diagnosed diabetes based on an oral glucose tolerance test predicts cardiovascular outcomes in patients with coronary artery disease: An observational study.

Chen WL, Sheu WH, Li YH, et al.

Medicine 2022; (101(28)):e29557 doi:10.1097/MD.0000000000029557.

Impact of Pharmaceutical Education on Medication Adherence and Its Clinical Efficacy in Patients with Type 2 Diabetes and Systemic Arterial Hypertension.

Contreras-Vergara A, Sifuentes-Franco S, Haack S, et al.

Patient preference and adherence 2022; (16()):1999-2007 doi:10.2147/PPA.S370323.

2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults.

Mancini GBJ, O'Meara E, Zieroth S, et al.

The Canadian journal of cardiology 2022; (38(8)):1153-1167 doi:10.1016/j.cjca.2022.04.029.

Patient reported outcome measures in children and adolescents with type 1 diabetes using advanced hybrid closed loop insulin delivery.

Gianini A, Suklan J, Skela-Savič B, et al.

Frontiers in endocrinology 2022; (13()):967725 doi:10.3389/fendo.2022.967725.

2021 Consensus Pathway of the Taiwan Society of Cardiology on Novel Therapy for Type 2 Diabetes.

Chiang CE, Ueng KC, Chao TH, et al.

JACC. Asia 2021; (1(2)):129-146 doi:10.1016/j.jacasi.2021.08.003.

The effect of different types of anemia on HbA1c levels in non-diabetics.

Alzahrani BA, Salamatullah HK, Alsharm FS, et al.

BMC endocrine disorders 2023; (23(1)):24 doi:10.1186/s12902-023-01280-y.

New Drug: Tirzepatide (Mounjaro™).

Gettman L

The Senior care pharmacist 2023; (38(2)):50-62 doi:10.4140/TCP.n.2023.50.

Diabetes remission of bariatric surgery and nonsurgical treatments in type 2 diabetes patients who failure to meet the criteria for surgery: a systematic review and meta-analysis.

Zhou X, Zeng C

BMC endocrine disorders 2023; (23(1)):46 doi:10.1186/s12902-023-01283-9.

Pathophysiology, Diagnostic Criteria, and Approaches to Type 2 Diabetes Remission.

Khamis AM

Cureus 2023; (15(1)):e33908 doi:10.7759/cureus.33908.

First-phase insulin secretion: can its evaluation direct therapeutic approaches?

Di Giuseppe G, Ciccarelli G, Soldovieri L, et al.

Trends in endocrinology and metabolism: TEM 2023; (34(4)):216-230 doi:10.1016/j.tem.2023.02.001.

Living with Type 2 Diabetes: Podcast of a Patient-Physician Discussion.

Kushner P, Dalin A

Diabetes therapy : research, treatment and education of diabetes and related disorders 2023; (14(4)):621-627 doi:10.1007/s13300-023-01378-5.

The concordance and discordance of diabetic kidney disease and retinopathy in patients with type 2 diabetes mellitus: A cross-sectional study of 26,809 patients from 5 primary hospitals in China.

Liu Z, Li X, Wang Y, et al.

Frontiers in endocrinology 2023; (14()):1133290 doi:10.3389/fendo.2023.1133290.

Gut hormone co-agonists for the treatment of obesity: from bench to bedside.

Nogueiras R, Nauck MA, Tschöp MH

Nature metabolism 2023; (5(6)):933-944 doi:10.1038/s42255-023-00812-z.

AGEs accumulation with vascular complications, glycemic control and metabolic syndrome: A narrative review.

Pal R, Bhadada SK

Bone 2023; (176()):116884 doi:10.1016/j.bone.2023.116884.

The concomitant use of sodium-glucose co-transporter 2 inhibitors improved the renal outcome of Japanese patients with type 2 diabetes treated with glucagon-like peptide 1 receptor agonists.

Kobayashi K, Toyoda M, Hatori N, et al.

Cardiovascular endocrinology & metabolism 2023; (12(4)):e0292 doi:10.1097/XCE.0000000000000292.

Diabetes Distress and Associations With Demographic and Clinical Variables: A Nationwide Population-Based Registry Study of 10,186 Adults With Type 1 Diabetes in Norway.

Hernar I, Cooper JG, Nilsen RM, et al.

Diabetes care 2024; (47(1)):126-131 doi:10.2337/dc23-1001.

Roadmap to the Effective Use of Continuous Glucose Monitoring by Diabetes Care and Education Specialists as Technology Champions.

Albanese-O'Neill A

Diabetes spectrum : a publication of the American Diabetes Association 2023; (36(4)):288-298 doi:10.2337/dsi23-0006.

Prevalence of diabetes distress and cross-cultural reliability of DDS-17 scale in rural Haryana.

Ranjan R, Rajput M, Sachdeva A, et al.

Journal of family medicine and primary care 2023; (12(9)):2064-2069 doi:10.4103/jfmpc.jfmpc_496_23.

Diabetes-related distress and quality of life among people with type 2 diabetes at primary care level in Brazil.

Neves NWT, Breder JSC, Oliveira BA, et al.

Acta diabetologica 2024; (61(4)):461-471 doi:10.1007/s00592-023-02216-7.

Improving Diabetes Control in a Medicaid Managed Care Population With Complex Needs.

Parchman ML, Stefanik-Guizlo K, Penfold RB, et al.

The Permanente journal 2024; (28(1)):62-67 doi:10.7812/TPP/23.106.

Implications of Iron Deficiency Anaemia on Glycemic Dynamics in Diabetes Mellitus: A Critical Risk Factor in Cardiovascular Disease.

Elsheikh E, Aljohani SS, Alshaikhmubarak MM, et al.

Cureus 2023; (15(11)):e49414 doi:10.7759/cureus.49414.

The Effect of Diabetes Management Shared Care Clinic on Glycated Hemoglobin A1c Compliance and Self-Management Abilities in Patients with Type 2 Diabetes Mellitus.

Jiang T, Liu C, Jiang P, et al.

International journal of clinical practice 2023; (2023()):2493634 doi:10.1155/2023/2493634.

Association Between Age at Diabetes Diagnosis and Subsequent Incidence of Cancer: A Longitudinal Population-Based Cohort.

Li Y, Tian J, Hou T, et al.

Diabetes care 2024; (47(3)):353-361 doi:10.2337/dc23-0386.

Long-Term Outcomes of Medical Management vs Bariatric Surgery in Type 2 Diabetes.

Courcoulas AP, Patti ME, Hu B, et al.

JAMA 2024; (331(8)):654-664 doi:10.1001/jama.2024.0318.

Potent incretin-based therapy for obesity: A systematic review and meta-analysis of the efficacy of semaglutide and tirzepatide on body weight and waist circumference, and safety.

Müllertz ALO, Sandsdal RM, Jensen SBK, Torekov SS

Obesity reviews : an official journal of the International Association for the Study of Obesity 2024; (25(5)):e13717 doi:10.1111/obr.13717.

Psychological resilience mediates the relationship between diabetes distress and depression among persons with diabetes in a multi-group analysis.

Wojujutari AK, Idemudia ES, Ugwu LE

Scientific reports 2024; (14(1)):6510 doi:10.1038/s41598-024-57212-w.

Modelling remission from overweight type 2 diabetes reveals how altering advice may counter relapse.

Hassell Sweatman CZW

Mathematical biosciences 2024; (371()):109180 doi:10.1016/j.mbs.2024.109180.

Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.

Karagiannis T, Malandris K, Avgerinos I, et al.

Diabetologia 2024; (67(7)):1206-1222 doi:10.1007/s00125-024-06144-1.

Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry.

Yeh YK, Lin KH, Sheu WH, et al.

BMC nephrology 2024; (25(1)):133 doi:10.1186/s12882-024-03567-1.

Assessing mortality risk in Type 2 Diabetes patients with prolonged ASCVD risk factors: the inclusive Poh-Ai predictive scoring system with CAC Score integration.

Lei MH, Hsu YC, Chung SL, et al.

Diabetology & metabolic syndrome 2024; (16(1)):104 doi:10.1186/s13098-024-01341-9.

GLP-1 Receptor Agonist Exposures Are Increasingly Common and Generally Associated with Mild Symptoms: A Single Poison Center Experience.

Marshall S, Ryan E, Rivera J, et al.

Journal of medical toxicology : official journal of the American College of Medical Toxicology 2024; (20(3)):278-285 doi:10.1007/s13181-024-01008-x.

The long-term effect of bariatric/metabolic surgery versus pharmacologic therapy in type 2 diabetes mellitus patients: A systematic review and meta-analysis.

Yang Y, Miao C, Wang Y, He J

Diabetes/metabolism research and reviews 2024; (40(5)):e3830 doi:10.1002/dmrr.3830.

Putting person-centred psychosocial diabetes care into practice: two psychosocial care pathways based on outcome preferences of people with diabetes and healthcare professionals.

Porth AK, Seidler Y, Long PA, et al.

BMJ mental health 2024; (27(1)) doi:10.1136/bmjment-2024-301061.

Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Neuen BL, Fletcher RA, Heath L, et al.

Circulation 2024; (150(22)):1781-1790 doi:10.1161/CIRCULATIONAHA.124.071689.

Redox signaling in the pancreas in health and disease.

Sastre J, Pérez S, Sabater L, Rius-Pérez S

Physiological reviews 2025; (105(2)):593-650 doi:10.1152/physrev.00044.2023.

Remission and relapse of diabetes after sleeve gastrectomy and one-anastomosis gastric bypass: The Tehran Obesity Treatment Study.

Sadeghi S, Hosseinpanah F, Khalaj A, et al.

Diabetes, obesity & metabolism 2024; (26(12)):6007-6015 doi:10.1111/dom.15974.

Impact of SGLT2 Inhibitors on Preventing Heart Failure Hospitalizations in Colombian Patients With Uncontrolled Type 2 Diabetes Mellitus.

Vernaza Trujillo DA, Rojas Bautista LY, Ramirez Espinosa CM, et al.

Cureus 2025; (17(1)):e77725 doi:10.7759/cureus.77725.

Incidence Trends of Type 2 Diabetes Mellitus, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian Children, Then (2006-2008) and Now (2017-2019).

Patel TJ, Ayub A, Bone JN, et al.

Pediatric diabetes 2023; (2023()):5511049 doi:10.1155/2023/5511049.

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.

Aronne LJ, Horn DB, le Roux CW, et al.

The New England journal of medicine 2025; (393(1)):26-36 doi:10.1056/NEJMoa2416394.

Cluster Analysis in Diabetes Research: A Systematic Review Enhanced by a Cross-Sectional Study.

Taurbekova B, Sarsenov R, Yaqoob MM, et al.

Journal of clinical medicine 2025; (14(10)) doi:10.3390/jcm14103588.

Characterizing trajectories of diabetes-related health parameters before diabetes diagnosis in diabetes subtypes: analysis of a 20-year long prospective cohort study in Sweden.

Liedtke TP, Strathmann EA, Ahlqvist E, et al.

Cardiovascular diabetology 2025; (24(1)):244 doi:10.1186/s12933-025-02786-6.

Systemic Review to Explore the Effect of Dyslipidaemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus: In Tertiary Care Center.

Singh A, Ambad RS, Jha RK

Journal of pharmacy & bioallied sciences 2025; (17(Suppl 1)):S127-S129 doi:10.4103/jpbs.jpbs_1976_24.

Risk factors for developing hypertension in patients with type 2 diabetes: A cross-sectional study.

Liu L, Mu J, Wang X, et al.

Medicine 2025; (104(26)):e43104 doi:10.1097/MD.0000000000043104.

Non-high-density lipoprotein cholesterol predicts cardiovascular risk better than remnant cholesterol in patients with type 2 diabetes mellitus.

Nsiah P, Acquah S, Bockarie AS, et al.

Frontiers in cardiovascular medicine 2025; (12()):1551203 doi:10.3389/fcvm.2025.1551203.

Diabetes-related distress among type 1 and type 2 diabetes patients in Saudi Arabia.

Soliman ES, Naguib R, Neimatallah F, et al.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 2025; (31(6)):404-415 doi:10.26719/2025.31.6.404.

Stratifying atherosclerotic cardiovascular disease by SMuRF burden in a Middle-Eastern country: A multiregistry study of demographics, comorbidities, and therapeutic trends.

Alkouri O, Albikawi Z, Saifan AR, et al.

PloS one 2025; (20(9)):e0332302 doi:10.1371/journal.pone.0332302.

Diabetes remission and diabetic complications of bariatric surgery vs. medical management in patients with type 2 diabetes: A meta-analysis of randomized controlled trials.

Cheng J, Yu H, Gu Y, et al.

Diabetes, obesity & metabolism 2025; (27(12)):7441-7453 doi:10.1111/dom.70152.

Pan-immune-inflammation value predicts proliferative diabetic retinopathy in patients with diabetes mellitus and atherosclerotic cardiovascular disease.

Kurtul A, Kurtul BE, Elbeyli A

Revista da Associacao Medica Brasileira (1992) 2025; (71(8)):e20250489 doi:10.1590/1806-9282.20250489.

Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Sweden.

Asplund O, Thangam M, Prasad RB, et al.

The lancet. Diabetes & endocrinology 2026; (14(1)):29-40 doi:10.1016/S2213-8587(25)00283-9.

Prevalence and associated factors of diabetes-related distress among type 2 diabetic patients in Africa: a systematic review and meta-analysis.

Feleke MG, Ashager K

BMC public health 2025; (25(1)):3994 doi:10.1186/s12889-025-25327-y.

Variability in the urinary albumin-to-creatinine ratio predicts mortality in patients with type 2 diabetes.

Wu JT, Li YH, Cheng YC, et al.

Journal of diabetes and its complications 2025; (40(2)):109249 doi:10.1016/j.jdiacomp.2025.109249.

Critical Relationship Between Iron Deficiency Anaemia (IDA) and Glycated Haemoglobin (HbA1c): An Updated Review.

Mahmood I, Hamza A, Fazry S, et al.

Mini reviews in medicinal chemistry 2026; (26(6)):389-398 doi:10.2174/0113895575401602251127012254.

Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA.

Li Z, Liu S, Ho JC, et al.

Diabetologia 2026; (69(6)):1545-1556 doi:10.1007/s00125-026-06687-5.

Does Continuous Glucose Monitoring Improve Glycemic Control and Quality of Life Among Adults With Type 2 Diabetes in Primary Care Settings? A Systematic Review and Meta-Analysis.

Park-Chong H, Benrimon M, Smaldone A

The science of diabetes self-management and care 2026; (52(4)):353-365 doi:10.1177/26350106261451194.

Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy.

Xiao MZ, Pang XX, Niu D, Chen RF

Frontiers in endocrinology 2026; (17()):1802069 doi:10.3389/fendo.2026.1802069.